Literature DB >> 1976359

Chronic graft-versus-host disease.

K M Sullivan.   

Abstract

Entities:  

Mesh：

Year:  1990        PMID： 1976359     DOI： 10.1007/978-1-4613-1493-6_5

Source DB:  PubMed          Journal:  Cancer Treat Res        ISSN： 0927-3042


× No keyword cloud information.
  7 in total

1.  Early recovery of T-cell function predicts improved survival after T-cell depleted allogeneic transplant.

Authors:  Jenna D Goldberg; Junting Zheng; Ravin Ratan; Trudy N Small; Kuan-Chi Lai; Farid Boulad; Hugo Castro-Malaspina; Sergio A Giralt; Ann A Jakubowski; Nancy A Kernan; Richard J O'Reilly; Esperanza B Papadopoulos; James W Young; Marcel R M van den Brink; Glenn Heller; Miguel-Angel Perales
Journal:  Leuk Lymphoma       Date:  2017-01-10

2.  GVHD prophylaxis with sirolimus-tacrolimus may overcome the deleterious effect on survival of HLA mismatch after reduced-intensity conditioning allo-SCT.

Authors:  R Parody; L Lopez-Corral; O L Godino; I G Cadenas; A P Martinez; L Vazquez; R Martino; C Martinez; C Solano; P Barba; D Valcarcel; T Caballero-Velazquez; F J Marquez-Malaver; J Sierra; D Caballero; J A Perez-Simón
Journal:  Bone Marrow Transplant       Date:  2014-10-13       Impact factor: 5.483

3.  Comparison of outcomes at two institutions of patients with ALL receiving ex vivo T-cell-depleted or unmodified allografts.

Authors:  G S Hobbs; A Hamdi; P D Hilden; J D Goldberg; M L Poon; C Ledesma; S M Devlin; G Rondon; E B Papadopoulos; A A Jakubowski; R J O'Reilly; R E Champlin; S Giralt; M-A Perales; P Kebriaei
Journal:  Bone Marrow Transplant       Date:  2015-01-26       Impact factor: 5.483

4.  Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndrome: Comparison of Outcomes between CD34+ Selected and Unmodified Hematopoietic Stem Cell Transplantation.

Authors:  Roni Tamari; Betul Oran; Patrick Hilden; Molly Maloy; Piyanuch Kongtim; Esperanza B Papadopoulos; Gabriela Rondon; Ann A Jakubowski; Borje S Andersson; Sean M Devlin; Sairah Ahmed; Uday R Popat; Doris Ponce; Julianne Chen; Craig Sauter; James W Young; Marcos de Lima; Miguel-Angel Perales; Richard J O'Reilly; Sergio A Giralt; Richard E Champlin; Hugo Castro-Malaspina
Journal:  Biol Blood Marrow Transplant       Date:  2018-01-08       Impact factor: 5.742

5.  Palifermin is efficacious in recipients of TBI-based but not chemotherapy-based allogeneic hematopoietic stem cell transplants.

Authors:  J D Goldberg; J Zheng; H Castro-Malaspina; A A Jakubowski; G Heller; M R M van den Brink; M-A Perales
Journal:  Bone Marrow Transplant       Date:  2012-07-02       Impact factor: 5.483

6.  The combination of sirolimus plus tacrolimus improves outcome after reduced-intensity conditioning, unrelated donor hematopoietic stem cell transplantation compared with cyclosporine plus mycofenolate.

Authors:  Jose Antonio Perez-Simón; Rodrigo Martino; Rocío Parody; Mónica Cabrero; Lucía Lopez-Corral; David Valcarcel; Carmen Martinez; Carlos Solano; Lourdes Vazquez; Francisco J Márquez-Malaver; Jordi Sierra; Dolores Caballero
Journal:  Haematologica       Date:  2012-10-12       Impact factor: 9.941

7.  T cell-depleted stem cell transplantation for adults with high-risk acute lymphoblastic leukemia: long-term survival for patients in first complete remission with a decreased risk of graft-versus-host disease.

Authors:  Jenna D Goldberg; Alex Linker; Deborah Kuk; Ravin Ratan; Joseph Jurcic; Juliet N Barker; Hugo Castro-Malaspina; Sergio Giralt; Katharine Hsu; Ann A Jakubowski; Robert Jenq; Guenther Koehne; Esperanza B Papadopoulos; Marcel R M van den Brink; James W Young; Farid Boulad; Nancy A Kernan; Richard J O'Reilly; Susan E Prockop; Joachim Yahalom; Glenn Heller; Miguel-Angel Perales
Journal:  Biol Blood Marrow Transplant       Date:  2012-09-13       Impact factor: 5.742
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.